TORONTO, ONTARIO / ACCESS Newswire / February 19, 2026 / Eco (Atlantic) Oil & Gas Ltd. (AIM: ECO, TSX â? V: EOG), the oil and gas exploration company focused on the offshore Atlantic Margins, announces that with effect from 19 February 2026, trading of the common shares in the capital of the Company ("Common Shares") […]
GomSpace delivers all-time high revenue, threefold growth in EBITDA, and secures major contracts for 2026, supported by a strong year-end balance sheet and cash position, as well as a 12% backlog increase on the full year. Fourth quarter of 2025 — Order intake increased by 5% to 144,698 T.SEK (138,454) — Revenue increased by 75%
(TSX:EPRX),(NASDAQ:EPRX), VICTORIA, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere(TM) technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the pricing of its previously announced public offering (the “Offering”) of 6,428,574
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants GlobeNewswire February 19, 2026 VICTORIA, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere(TM) technology designed to optimize local, controlled drug delivery for applications
Enterprise transformation SaaS company enters Top 20 of Tussell's independent ranking of the fastest-growing UK public sector technology suppliers Bizzdesign has ranked 17th in the 2026 Tech200, Tussell's annual list of the 200 fastest-growing tech suppliers to the UK public sector. The ranking, developed in partnership with techUK and The Data City, and based on
Vancouver, British Columbia–(Newsfile Corp. – February 19, 2026) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a Health Canada-licensed manufacturer of pharmaceutical-grade psychedelic drug products, today announced the export of its GMP-manufactured natural 5 mg psilocybin capsules to Australia for the treatment of patients diagnosed with treatment-resistant depression (TRD)
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU Prolacta Bioscience® today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human milk-based fortifier, as a prescription drug for very low birth weight infants, infants with congenital gastrointestinal
MADRID, Feb. 19, 2026 (GLOBE NEWSWIRE) — Telefonica, S.A., a global leader in integrated communications, and Mavenir Systems Limited, the telco-first, cloud-native, AI-by-design technology provider, today announced the signing of a landmark Memorandum of Understanding (MOU) to create a joint AI Innovation Hub. This collaborative lab is designed to accelerate the integration of artificial intelligence
The Supervisory Board and Executive Board of SAP SE (NYSE: SAP) recommend that shareholders approve a dividend of EUR 2.50 per share for fiscal year 2025. This is an increase of EUR 0.15, or 6.4% compared to the dividend paid for fiscal year 2024. If approved by shareholders and assuming the same level of treasury
Telefonica and Mavenir Forge Strategic Partnership to Accelerate AI Innovation in Telecom Showcasing AI innovation at Mobile World Congress (#MWC26) with live product demonstrations of next generation use cases GlobeNewswire February 19, 2026 MADRID, Feb. 19, 2026 (GLOBE NEWSWIRE) — Telefonica, S.A., a global leader in integrated communications, and Mavenir Systems Limited, the telco-first, cloud-native,